Learn More
The number of patients with primary prophylactic ICD implantation rises. Resources for a regular ICD follow- up every 3 months are not available. The REFORM Study investigated in a prospective, randomized and multicenter comparison study the effect of ICD home monitoring (HM) against conventional follow-up (FU) in MADIT II patients: A special focus was on(More)
  • J. Geller
  • The Urologic clinics of North America
  • 1991
Megestrol acetate plus low-dose estrogen may be an effective, low-cost alternative to pharmacologic or surgical castration plus flutamide in the management of patients with advanced prostate cancer. The potential benefit of combined androgen ablation achieved by any means in comparison with conventional hormonal therapy appears to be limited.